Skip to content

Change in olfactory perception during psychotherapeutic treatment of patients with depressive disorder

Change in olfactory perception during psychotherapeutic treatment of patients with depressive disorder - COPD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00012970
Enrollment
60
Registered
2017-10-24
Start date
2017-10-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: The olfactory perception (perception threshold, discrimination, identification) of Patients with depressive disorder will be examined at three time points (before the start of a psychotherap

Sponsors

Universität des SaarlandesKlinische Psychologie und Psychotehrapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patient sample: Depressive disorder as primary diagnosis, participation in cognitive behavioral therapy Control group: healthy volunteers

Exclusion criteria

Exclusion criteria: Patients: Drug or substance abuse, permanent use of medication (exception: oral contraceptives or occasional use of headache tablets up to one week before the beginning of the study, prescribed psychopharmaceuticals) Control group: Mental disorder, drug or substance abuse, permanent administration of medications (exception: oral contraceptives or occasional use of headache tablets up to one week before the start of the study)

Design outcomes

Primary

MeasureTime frame
Examination of the presence of deficits in olfactory perception (perception threshold, discrimination, identification) in patients with depression compared to a healthy control group adjusted for age and sex. The olfactory perception is measured in all dimensions with the Sniffin 'Sticks. Change of the olfactory perception (perception threshold, discrimination, identification) in the course of the therapy. Predictability of the change in symptom stress, recorded by the BDI, in the course of the therapy based on the olfactory perception. Three survey days: 1) before the start of therapy (during or after the probatory sessions), 2) after the 12th therapies session, 3) after the 24th therapies session.

Secondary

MeasureTime frame
Diagnostic Interview using SKID. Examination of the correlation between olfactory performance and the severity of comorbidities like e.g. anxiety disorders (BSI).

Countries

Germany

Contacts

Public ContactChristian Schanz

Universität des SaarlandesKlinische Psychologie und Psychotherapie

christian.schanz@uni-saarland.de++49 +681 302 71005

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026